Skip to main content

Advertisement

SpringerLink
Log in

Eosinophilic Esophagitis: Current Treatment

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Eosinophilic esophagitis (EoE) is a relatively new entity with a significant amount of increased recognition over the last decade. The mainstay treatments of EoE are designed to eliminate the causative allergens or to reduce their effects on the esophageal mucosa. Common treatments include dietary modification, proton pump inhibitors, systemic and topical corticosteroids, and endoscopic treatments. As the pathogenesis of EoE is explored, new and novel treatments are being studied that target specific pathways and chemokines identified in as precipitating agents of EoE. This is a rapidly evolving field with significant ongoing research and clinical studies. Our review will therefore focus on current and novel treatment approaches to the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298–1301.

    PubMed  CAS  Google Scholar 

  2. Furuta GT, Liacouras CA, Clooins MH, et al. First International Gastrointestinal Eosinophil Research Symposium (FIGERS) subcommittees: eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.

    Article  PubMed  CAS  Google Scholar 

  3. Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr. 2003;27:S23–S28.

    Article  Google Scholar 

  4. Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H. Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation. J Gastroenterol. 2012 [Epub ahead of print].

  5. Noel R, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941.

    Article  PubMed  CAS  Google Scholar 

  6. Shi YN, Sun SJ, Xiong LS, Cao QH, Cui Y, Chen MH. Prevelence, clinical manifestations and endoscopic features of eosinophilic esophagitis: a pathological review in China. J Dig Dis. 2012;13:304–309.

    Article  PubMed  CAS  Google Scholar 

  7. Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic eosophagitis in patients presenting with dysphagia—a prospective analysis. Aliment Pharmacol Ther. 2008;28:1140–1146.

    Article  PubMed  CAS  Google Scholar 

  8. Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102:2627–2632.

    Article  PubMed  Google Scholar 

  9. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801.

    Article  PubMed  Google Scholar 

  10. Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology or eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055–1061.

    Article  PubMed  Google Scholar 

  11. Whitney-Miller CL, Katzka D, Furth EE. Eosinophilic esophagitis: a retrospective review of esophageal biopsy specimens from 1992 to 2004 at an adult academic medical center. Am J Clin Pathol. 2009;131:788–792.

    Article  PubMed  Google Scholar 

  12. Vanderheyden AD, Petras RE, DeYoung BR, Mitros FA. Emerging eosinophilic (allergic) esophagitis: increased incidence or increased recognition. Arch Pathol Lab Med. 2007;131:777–779.

    PubMed  Google Scholar 

  13. Liacouras CA, Wenner WJ, Brown K, Buchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380–385.

    Article  PubMed  CAS  Google Scholar 

  14. Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828–833.

    Article  PubMed  Google Scholar 

  15. Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6:531.

    Article  PubMed  Google Scholar 

  16. Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90.

    Article  PubMed  CAS  Google Scholar 

  17. Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41:451.

    Article  PubMed  Google Scholar 

  18. Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology. 2010;139:182.

    Article  PubMed  CAS  Google Scholar 

  19. Bullock JZ, Villanueva JM, Blanchard C, et al. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:22–31.

    Article  PubMed  CAS  Google Scholar 

  20. Frederickson NW, Lee YJ, Redd MK, Go J, Valestin J, Schey R. Lack of seasonal variation in the incidence of eosinophilic esophagitis (abstract). Gastroenterology. 2012;142:S437–S438.

    Google Scholar 

  21. Swoger JM, Weiler CR, Arora AS. Eosinophilic esophagitis: is it all allergies? Mayo Clin Proc. 2007;82:1541–1549.

    Article  PubMed  Google Scholar 

  22. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206.

    Article  PubMed  Google Scholar 

  23. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110–117.

    Article  PubMed  CAS  Google Scholar 

  24. Shah A, Kagalwalla AF, Gonsalves N, Melin-Aldana H, Li BU, Hirano I. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol. 2009;104:716–721.

    Article  PubMed  Google Scholar 

  25. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.

    Article  PubMed  Google Scholar 

  26. Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:435–442.

    Article  PubMed  Google Scholar 

  27. Krarup AL, Villadsen GE, Mejlgaard E, Olesen SS, Drewes AM, Funch-Jensen P. Acid hypersensitivity in patients with eosinophilic eosophagitis. Scand J Gastroenterol. 2010;45:273–281.

    Article  PubMed  CAS  Google Scholar 

  28. Zhang X, Cheng E, Huo X, et al. In esophageal squamous epithelial cell lines from patients with eosinophilic esophagitis (EoE), omeprazole blocks the stimulated secretion of eotaxin 3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology. 2010;138:S-122.

    Article  Google Scholar 

  29. Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313–1319.

    Article  PubMed  Google Scholar 

  30. Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci. 2012;57:1413–1419.

    Article  PubMed  Google Scholar 

  31. Faubion WA Jr, Perrault J, Burgart LG, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90–93.

    Article  PubMed  Google Scholar 

  32. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381–1391.

    Article  PubMed  CAS  Google Scholar 

  33. Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526–1537.

    Article  PubMed  CAS  Google Scholar 

  34. Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109–116.

    Article  PubMed  CAS  Google Scholar 

  35. Helou EF, Simonson J, Arora A. 3 Year-follow up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:2194–2199.

    Article  PubMed  Google Scholar 

  36. Schroeder S, Fleischer DM, Masterson JC, Gelfand E, Furuta GT, Atkins D. Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol. 2012;129:1219–1221.

    Article  Google Scholar 

  37. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165–173.

    Article  PubMed  CAS  Google Scholar 

  38. Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut. 2003;52:181–185.

    Article  PubMed  CAS  Google Scholar 

  39. Lucendo AJ, De Rezende LC, Jimenez-Contreras S, et al. Montelukast was inefficient in maintaining steroid induced remission in adult eosinophilic esophagitis. Dig Dis Sci. 2011;56:3551–3558.

    Article  PubMed  CAS  Google Scholar 

  40. Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312–1319.

    Article  PubMed  CAS  Google Scholar 

  41. Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic eosophagitus: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59:21–30.

    Article  PubMed  CAS  Google Scholar 

  42. Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129:456–463.

    Article  PubMed  CAS  Google Scholar 

  43. Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122:425–427.

    Article  PubMed  CAS  Google Scholar 

  44. Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol. 2005;115:459–465.

    Article  PubMed  CAS  Google Scholar 

  45. Straumann A, Bussmann C, Perkins MC, et al. Treatment of eosinophilic esophagitis with the CRTH2-antagonist Oc000459: a novel therapeutic principle (abstract). Gastroenterology. 2012;142:S147.

    Google Scholar 

  46. Kagalwalla AF, Sentongo TA, Ritz S, et al. LuBU: effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1097–1102.

    Article  PubMed  Google Scholar 

  47. Thompson JS, Lebwohl B, Reilly NR, Talley NJ, Bhaqat G, Green PH. Increased incidence of eosinophilic esophagitis in children and adults with celiac disease. J Clin Gastroenterol. 2012;36:e6–e11.

    Article  Google Scholar 

  48. Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95:336–343.

    Article  PubMed  Google Scholar 

  49. Gonsalves N., Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142:1451–1459.

    Google Scholar 

  50. Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc. 2010;71:713–714.

    Article  PubMed  Google Scholar 

  51. Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011;73:14–21.

    Article  Google Scholar 

  52. Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc. 2010;71:706–712.

    Article  PubMed  Google Scholar 

  53. Ally MR, Dias J, Veerappan GR, et al. Safety of dilation in adults with eosinophilic esophagitis. Dis Esophagus. 2012. doi:10.1111/j.1442-2050.2012.01363.x

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Matthew Redd & Ron Schey

Authors
  1. Matthew Redd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ron Schey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ron Schey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Redd, M., Schey, R. Eosinophilic Esophagitis: Current Treatment. Dig Dis Sci 58, 613–620 (2013). https://doi.org/10.1007/s10620-012-2383-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2383-1

Keywords

Search

Navigation